(Q43725033)

26 November 2017

title

Antiphospholipid antibody levels in intravenous immunoglobulin (IVIg) preparations (English)

1 reference

26 November 2017

5

Y Shoenfeld

1 reference

26 November 2017

1

Y Sherer

1 reference

26 November 2017

R Wu

2

1 reference

26 November 2017

I Kraus

series ordinal

3

1 reference

26 November 2017

J B Peter

series ordinal

4

1 reference

26 November 2017

publication date

1 January 2001

1 reference

26 November 2017

1 reference

26 November 2017

volume

10

1 reference

26 November 2017

issue

8

1 reference

26 November 2017

page(s)

568-570

1 reference

A study of 20 SLE patients with intravenous immunoglobulin--clinical and serologic response

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1191%2F096120301701549705

Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120301701549705

Intravenous immunoglobulin therapy of antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120301701549705

Anti-DNA and antiphospholipid antibodies in IVIG preparations: in vivo study in naive mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120301701549705

Beta2GP-I in the anti phospholipid (Hughes') syndrome--from a cofactor to an autoantigen--from induction to prevention of antiphospholipid syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120301701549705

Adverse effects of intravenous immunoglobulin therapy in 56 patients with autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120301701549705

10.1191/096120301701549705

21 January 2018

Identifiers

DOI

1 reference

26 November 2017

1 reference